Skip to content

Join Us
Members Area

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Publication Category: Cancer

Characterization of Surface Receptor Expression and Cytotoxicity of Human NK Cells and NK Cell Subsets in Overweight and Obese Humans

W. Naujoks; D. Quandt; A. Hauffe; H. Kielstein; I. Bähr; J. Spielmann Characterization of Surface Receptor Expression and Cytotoxicity of Human NK Cells and NK Cell Subsets in Overweight and Obese Humans Front Immunol

Metabolic reprogramming of natural killer cells in obesity limits antitumor responses

X. Michelet; L. Dyck; A. Hogan; R. M. Loftus; D. Duquette; K. Wei; S. Beyaz; A. Tavakkoli; C. Foley; R. Donnelly; C. O'Farrelly; M. Raverdeau; A. Vernon; W. Pettee; D. O'Shea; B. S. Nikolajczyk; K. H. G. Mills; M. B. Brenner; D. Finlay; L. Lynch Metabolic reprogramming of natural killer cells in obesity limits antitumor responses Nat Immunol

Invariant NKT cells and CD1d(+) cells amass in human omentum and are depleted in patients with cancer and obesity

L. Lynch; D. O'Shea; D. C. Winter; J. Geoghegan; D. G. Doherty; C. O'Farrelly Invariant NKT cells and CD1d(+) cells amass in human omentum and are depleted in patients with cancer and obesity Eur J Immunol

Acceptability of a Mobile Health Behavior Change Intervention for Cancer Survivors With Obesity or Overweight: Nested Mixed Methods Study Within a Randomized Controlled Trial

J. M. Groarke; J. Richmond; J. Mc Sharry; A. Groarke; O. M. Harney; M. G. Kelly; J. C. Walsh Acceptability of a Mobile Health Behavior Change Intervention for Cancer Survivors With Obesity or Overweight: Nested Mixed Methods Study Within a Randomized Controlled Trial JMIR Mhealth Uhealth

Deciphering the complex interplay between pancreatic cancer, diabetes mellitus subtypes and obesity/BMI through causal inference and mediation analyses

E. Molina-Montes; C. Coscia; P. Gómez-Rubio; A. Fernández; R. Boenink; M. Rava; M. Márquez; X. Molero; M. Löhr; L. Sharp; C. W. Michalski; A. Farré; J. Perea; M. O'Rorke; W. Greenhalf; M. Iglesias; A. Tardón; T. M. Gress; V. M. Barberá; T. Crnogorac-Jurce Deciphering the complex interplay between pancreatic cancer, diabetes mellitus subtypes and obesity/BMI through causal inference and mediation analyses Gut
Insulin Resistance & Diabetes

Metabolic Syndrome and Risk of Gastrointestinal Cancers: An Investigation Using Large-scale Molecular Data

J. A. Rothwell; M. Jenab; M. Karimi; T. Truong; Y. Mahamat-Saleh; P. Ferrari; S. G. Dashti; T. Kühn; A. J. Cross; G. Severi; M. J. Gunter; N. Murphy Metabolic Syndrome and Risk of Gastrointestinal Cancers: An Investigation Using Large-scale Molecular Data Clinical Gastroenterology and Hepatology
Metabolic Syndrome

Metabolic syndrome and leptin are associated with adverse pathological features in male colorectal cancer patients

L. A. Healy; J. M. Howard; A. M. Ryan; P. Beddy; B. Mehigan; R. Stephens; J. V. Reynolds Metabolic syndrome and leptin are associated with adverse pathological features in male colorectal cancer patients Colorectal Dis
Metabolic Syndrome

The development of the metabolic syndrome and insulin resistance after adjuvant treatment for breast cancer

E. M. Guinan; E. M. Connolly; L. A. Healy; P. A. Carroll; M. J. Kennedy; J. Hussey The development of the metabolic syndrome and insulin resistance after adjuvant treatment for breast cancer Cancer Nursing
Insulin Resistance & Diabetes Metabolic Syndrome

Visceral Obesity, Metabolic Syndrome, and Esophageal Adenocarcinoma

J. A. Elliott; J. V. Reynolds Visceral Obesity, Metabolic Syndrome, and Esophageal Adenocarcinoma Front Oncol
Metabolic Syndrome

Visceral obesity, metabolic syndrome, insulin resistance and cancer

S. L. Doyle; C. L. Donohoe; J. Lysaght; J. V. Reynolds Visceral obesity, metabolic syndrome, insulin resistance and cancer Proc Nutr Soc
Insulin Resistance & Diabetes Metabolic Syndrome

Older posts

Newer posts

← Previous Page1 … Page5 Page6 Page7 … Page11 Next →

Search for:

Recent Posts

9th ASOI Annual Conference – Registration now open!
Press Release for World Obesity Day 4th March 2024
ASOI and ICPO response to : Medical Council Communication: “Important medicine shortage information – Ozempic (semaglutide)”
Things to do in Dublin during ECO
ECO 2023 sponsorship update

ASOI

info@asoi.info

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Privacy Policy
Site Map

©2026 ASOI